Novel Self-Regulating Thyroid Hormone Replacement Therapy

This work presents a novel hormone replacement therapy that eliminates the dependence on levothyroxine through an innovative intelligent biofeedback approach. By integrating genetic engineering, bioelectronics, and synthetic biology, we have developed an encapsulated cell-based system capable of autonomously regulating thyroid hormone production, avoiding the adverse effects of conventional treatment.
This "bio-artificial thyroid system" continuously monitors hormone levels in real-time and adjusts the secretion of T3/T4 or selective thyroid analogs based on the patient's metabolic needs, preventing both hypothyroid and hyperthyroid symptoms. By implementing a self-regulating closed-loop control, this therapy restores thyroid function dynamically, providing a side-effect-free alternative to traditional levothyroxine.